ABSTRACT
Although both short and long sleep duration are associated with elevated hypertension risk, our understanding of their interplay with biological pathways governing blood pressure remains limited. To address this, we carried out genome-wide cross-population gene-by-short-sleep and long-sleep duration interaction analyses for three blood pressure traits (systolic, diastolic, and pulse pressure) in 811,405 individuals from diverse population groups. We discover 22 novel gene-sleep duration interaction loci for blood pressure, mapped to 23 genes. Investigating these genes' functional implications shed light on neurological, thyroidal, bone metabolism, and hematopoietic pathways that necessitate future investigation for blood pressure management that caters to sleep health lifestyle. Non-overlap between short sleep (12) and long sleep (10) interactions underscores the plausible nature of distinct influences of both sleep duration extremes in cardiovascular health. Several of our loci are specific towards a particular population background or sex, emphasizing the importance of addressing heterogeneity entangled in gene-environment interactions, when considering precision medicine design approaches for blood pressure management.
ABSTRACT
Although both short and long sleep duration are associated with elevated hypertension risk, our understanding of their interplay with biological pathways governing blood pressure remains limited. To address this, we carried out genome-wide cross-population gene-by-short-sleep and long-sleep duration interaction analyses for three blood pressure traits (systolic, diastolic, and pulse pressure) in 811,405 individuals from diverse population groups. We discover 22 novel gene-sleep duration interaction loci for blood pressure, mapped to genes involved in neurological, thyroidal, bone metabolism, and hematopoietic pathways. Non-overlap between short sleep (12) and long sleep (10) interactions underscores the plausibility of distinct influences of both sleep duration extremes in cardiovascular health. With several of our loci reflecting specificity towards population background or sex, our discovery sheds light on the importance of embracing granularity when addressing heterogeneity entangled in gene-environment interactions, and in therapeutic design approaches for blood pressure management.
ABSTRACT
OBJECTIVE: This study aims to identify BMI-associated genes by integrating aggregated summary information from different omics data. METHODS: We conducted a meta-analysis to leverage information from a genome-wide association study (n = 339 224), a transcriptome-wide association study (n = 5619), and an epigenome-wide association study (n = 3743). We prioritized the significant genes with a machine learning-based method, netWAS, which borrows information from adipose tissue-specific interaction networks. We also used the brain-specific network in netWAS to investigate genes potentially involved in brain-adipose interaction. RESULTS: We identified 195 genes that were significantly associated with BMI through meta-analysis. The netWAS analysis narrowed down the list to 21 genes in adipose tissue. Among these 21 genes, six genes, including FUS, STX4, CCNT2, FUBP1, NDUFS3, and RAPSN, were not reported to be BMI-associated in PubMed or GWAS Catalog. We also identified 11 genes that were significantly associated with BMI in both adipose and whole brain tissues. CONCLUSION: This study integrated three types of omics data and identified a group of genes that have not previously been reported to be associated with BMI. This strategy could provide new insights for future studies to identify molecular mechanisms contributing to BMI regulation.
Subject(s)
Genome-Wide Association Study , Multiomics , Humans , Body Mass Index , Genome-Wide Association Study/methods , Transcriptome , Obesity/genetics , Cyclin T/genetics , DNA-Binding Proteins/genetics , RNA-Binding Proteins/geneticsABSTRACT
Fast development of space technologies poses a strong challenge for elastic materials, which need to be not only lightweight, strong and compliant, but also able to maintain stable elasticity over a wide temperature range1-4. Here we report a lightweight magnesium-scandium strain glass alloy (Mg with 21.3 at.% Sc) that meets this challenge. This alloy is as light (density ~2 g cm-3) and compliant as organic-based materials5-7 like bones and glass fibre reinforced plastics, but in contrast with those materials, it possesses a nearly temperature-independent (or Elinvar-type), ultralow Young's modulus (~20-23 GPa) over a wide temperature range from room temperature down to 123 K; a higher yield strength of ~200-270 MPa; and a long fatigue life of over one million cycles. As a result, it exhibits a relatively high, temperature-independent elastic energy density of ~0.5 kJ kg-1 among known materials at a moderate stress level of 200 MPa. We show that its exceptional properties stem from a strain glass transition, and the Elinvar-type elasticity originates from its moderate elastic softening effect cancelling out the ever-present elastic hardening. Our findings provide insight into designing materials that possess unconventional and technologically important elastic properties.